Churg Strauss Drug Approved by FDA

Churg Strauss Drug Approved by FDA

December 12, 2017 - The United States Food and Drug Administration (FDA) has approved Nucala (Mepolizumab) to treat Churg Strauss Syndrome (Eosinophilic Granulomatosis with Polyangiitis).

Here is the full Press Release Nucala - Churg Strauss Drug Approved by FDA

Content written and posted by Ken Abbott abbottsystems@gmail.com